# Megafine Pharma (P) Limited - Inspection Records

Source: https://www.keypedia.com/companies/megafine-pharma-p-limited/47f3a083-30b0-4f15-ac09-3f99d5e75442

> Inspection records and compliance data for Megafine Pharma (P) Limited in Vapi, None. Access full analysis and detailed observations.

---

## Details

- Name: Megafine Pharma (P) Limited
- FEI Number: 3006688078
- City: Vapi
- State: None
- Country Name: India
- Address Line 1: 911 & 912 Phase Iii Gidc
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1207908 - Megafine Pharma (P) Limited - 2023-05-12](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/893a79ec-a5e0-4761-81fc-eb0afaf7a88c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 12, 2023
- [483 - Megafine Pharma (P) Limited - 2023-05-08](https://www.keypedia.com/records/483/megafine-pharma-p-limited/6ca92725-e717-40fe-a512-f3deb67e14eb) — source: FDA, date: May 8, 2023
- [FDA Inspection 1121027 - Megafine Pharma (P) Limited - 2020-02-21](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/5f85e976-c20c-4539-8fd3-024d158e4a23) — classification: Official Action Indicated (OAI), source: FDA, date: February 21, 2020
- [FDA Inspection 1058583 - Megafine Pharma (P) Limited - 2018-06-15](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/5f17d11f-808d-4615-843d-37ed847ce74a) — classification: Official Action Indicated (OAI), source: FDA, date: June 15, 2018
- [FDA Inspection 988000 - Megafine Pharma (P) Limited - 2016-09-23](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/44d0f909-d360-496d-a78c-eb1dd8497734) — classification: Official Action Indicated (OAI), source: FDA, date: September 23, 2016
- [FDA Inspection 828506 - Megafine Pharma (P) Limited - 2013-03-13](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/bc910809-b46a-4e10-bcd8-e6930da6f8b3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2013

## Related Companies

- [Chifeng Pharmaceutical Company, Ltd.](https://www.keypedia.com/companies/chifeng-pharmaceutical-company-ltd/3b71193c-338c-4461-ba6b-51e9f1b9711a)
- [Loba Feinchemie GmbH](https://www.keypedia.com/companies/loba-feinchemie-gmbh/93a4c987-38d4-4552-a112-08159d4b61f5)
- [Aurorium LLC](https://www.keypedia.com/companies/aurorium-llc/be33974b-e9e5-4d3e-9e45-52348f2d23d3)
- [Ames Goldsmith Corporation](https://www.keypedia.com/companies/ames-goldsmith-corporation/0c9c7a1f-10cc-4a11-9136-632fc42dbd63)
- [Zhejiang Lepu Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-lepu-pharmaceutical-co-ltd/3f04f71b-33ea-46db-b25c-d115b2c88686)
- [Nippon Rika Co., Ltd.](https://www.keypedia.com/companies/nippon-rika-co-ltd/28d4ba43-fd16-42e5-9335-0a449b2f57eb)
- [Jiangsu Tianhe Pharmaceutical Co.](https://www.keypedia.com/companies/jiangsu-tianhe-pharmaceutical-co/163c477d-b837-4e85-8b5e-9cc8f2fc3fcd)
- [Pucheng Chia Tai Biochemical Co. Ltd. - Putan Factory](https://www.keypedia.com/companies/pucheng-chia-tai-biochemical-co-ltd-putan-factory/dbec167d-d588-49dc-bd27-42205ea16011)
- [Aragen Life Sciences Limited](https://www.keypedia.com/companies/aragen-life-sciences-limited/7d982e4a-6c1e-474c-b5c8-0a0286628be7)
- [Central Glass Co., Ltd.](https://www.keypedia.com/companies/central-glass-co-ltd/df9e20f9-4cd5-4ab6-b166-4216c0d628db)

## Related Officers

- [Investigator](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)
- [Consumer Safety Officer/ Federal Investigator](https://www.keypedia.com/people/lisa-l-flores/465a6807-55d7-4c3f-a415-c21ac4517bc9)